Key Financial Performance Figures (FY2025-26)
- Revenue from operations: ₹328.87 crore (24.5% year-on-year growth)
- EBITDA: ₹34.26 crore (32.6% year-on-year growth)
- Profit After Tax: ₹16.52 crore (29.0% year-on-year growth)
- Net debt-to-equity ratio improved from 1.18x to 0.74x during FY2025-26
IPO Proceeds Deployment Strategy
The IPO proceeds (from November 2025 BSE SME listing) are being deployed primarily towards:
- Development of new technical manufacturing facility at Dahej, Gujarat (largest strategic allocation)
- Formulation and warehouse infrastructure
- Working capital requirements
- General corporate purposes
The Dahej facility implementation is being undertaken in phases without change in underlying project scope, capacity, or overall objects of the IPO.
Manufacturing Expansion and Backward Integration
- Dahej formulation facility expansion, R&D, and pilot plant targeted for completion by December 2026
- Technical manufacturing unit expected to begin production in 2027
- Received CIB&RC approvals for Technical Indigenous Manufacture (TIM) covering 25 molecules
- Process development and preparations for commercial production are ongoing
- Both imported technical (under 9(3) TI category) and indigenous technical production will continue in parallel
Product Portfolio Development
Domestic Commercialized Brands: KAZERO™, KISERU™, PYROFONE™, ARUBA™
Domestic Planned Launches (FY2026-27): ARUBA TWIN™, MIRAI 500™, SPINOSTAR™
Biological Crop Care Planned Launches: MAHAFLORA™, MAHABASSIA™, NEEMFORCE+™
Export Portfolio Available Internationally: PRIME™, FOSELAN™, PESTRON™, SPINOVA 480™, PILARKING MAX™, LAVIRON 5G™, MAYANILE, TYPIC, EMPUSA
International Market Expansion
Current Registered Export Markets: Australia, Dominican Republic, Egypt, Turkey, Ethiopia, Oman, Taiwan, Jordan, Uganda, UAE
Registration Progress in: Brazil, Colombia, Paraguay, Peru (Latin America); Vietnam, Taiwan (Asia); Yemen, Saudi Arabia, Armenia, Lebanon
Growth Strategy and Outlook
- Growth driven by cropprotection formulations business across insecticides, fungicides, herbicides, and biological products
- Predominantly B2B and institutional customer base currently
- Expanding own-brand domestic business (initiated in South India, extending to Central India)
- Developing export business through product registrations and market-development capabilities
- R&D focus on advanced formulations, combination products, and biological solutions
- Expecting patent protection for innovations in near future
Management Commentary on Market Environment
- India relatively resilient but not insulated from global pressure
- Challenges include Middle East disruption, price competition, channel inventory, raw-material and currency volatility, monsoon variability, restrictions on older molecules, and tighter regulation
- Strategy includes staying close to demand, increasing manufacturing capacity utilization, selective trading and inventory management
- Focus on differentiated, biological and bio-fermented products addressing sustainability and residue concerns
Five-Year Vision
- Sustainability becoming central to company's role
- Strengthening manufacturing capabilities and broadening product portfolio
- Expanding domestic branded business and international presence
- Building intellectual property through R&D investment
- Disciplined capital allocation, transparent reporting, and stronger governance as a listed company